Edesa Biotech, Inc. Common Shares (EDSA)
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases. The company specializes in leveraging its proprietary microscopic antibody technology to create therapies that address unmet medical needs. Edesa's research primarily targets conditions such as allergic and autoimmune diseases, aiming to advance novel therapeutic options in these areas.
Company News
Over 18 pharmaceutical companies are developing targeted therapies for vitiligo, with promising pipeline drugs showing potential to transform treatment options beyond conventional approaches like corticosteroids and phototherapy.
Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape Lifesciences shares jumped 44.6% to $0.3630 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers RiskOn Interna...